Financial results - HEMIMUNOLOGIS S.R.L.

Financial Summary - Hemimunologis S.r.l.
Unique identification code: 8631732
Registration number: J08/837/1996
Nace: 8690
Sales - Ron
5.810
Net Profit - Ron
-7.351
Employees
1
Open Account
Company Hemimunologis S.r.l. with Fiscal Code 8631732 recorded a turnover of 2024 of 5.810, with a net profit of -7.351 and having an average number of employees of 1. The company operates in the field of Alte activitati referitoare la sanatatea umana having the NACE code 8690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Hemimunologis S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 22.100 28.642 41.391 35.390 19.590 20.218 13.965 14.412 9.602 5.810
Total Income - EUR 22.598 28.864 41.865 42.863 19.656 20.330 14.295 15.124 10.130 15.163
Total Expenses - EUR 11.548 15.612 18.057 15.536 15.640 16.702 17.694 20.004 20.510 22.106
Gross Profit/Loss - EUR 11.050 13.252 23.809 27.327 4.016 3.628 -3.399 -4.880 -10.380 -6.943
Net Profit/Loss - EUR 10.372 12.675 23.365 26.898 3.819 3.442 -3.539 -5.022 -10.480 -7.351
Employees 1 1 1 1 2 1 2 1 2 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -39.2%, from 9.602 euro in the year 2023, to 5.810 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Hemimunologis S.r.l.

Rating financiar

Financial Rating -
HEMIMUNOLOGIS S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Hemimunologis S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Hemimunologis S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Hemimunologis S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Hemimunologis S.r.l. - CUI 8631732

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 1.635 1.923 1.470 1.243 1.219 2.461 1.992 592 273 1.625
Current Assets 101.280 75.540 74.276 99.266 101.473 101.868 95.752 83.995 57.722 2.619
Inventories 1 0 0 0 0 0 0 0 0 0
Receivables 60.989 23.434 33.414 38.117 33.236 29.329 22.553 16.019 2.462 247
Cash 13.297 25.387 3.180 23.991 31.732 36.615 29.655 26.001 25.519 2.372
Shareholders Funds 100.234 75.145 73.558 99.106 101.007 102.534 96.721 83.483 56.514 -1.411
Social Capital 47 47 46 45 44 43 42 43 42 42
Debts 2.680 2.317 2.188 1.402 1.685 1.795 1.023 1.104 1.481 5.655
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8690 - 8690"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.619 euro in 2024 which includes Inventories of 0 euro, Receivables of 247 euro and cash availability of 2.372 euro.
The company's Equity was valued at -1.411 euro, while total Liabilities amounted to 5.655 euro. Equity decreased by -57.609 euro, from 56.514 euro in 2023, to -1.411 in 2024.

Risk Reports Prices

Reviews - Hemimunologis S.r.l.

Comments - Hemimunologis S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.